Display options
Cite
Risk MC, Masterson TA. Intratubular germ cell neoplasms of the testis and bilateral testicular tumors: clinical significance and management options. Indian J Urol. 2010;26(1):64-71doi: 10.4103/0970-1591.60454.
Risk, M. C., & Masterson, T. A. (2010). Intratubular germ cell neoplasms of the testis and bilateral testicular tumors: clinical significance and management options. Indian journal of urology : IJU : journal of the Urological Society of India, 26(1), 64-71. https://doi.org/10.4103/0970-1591.60454
Risk, Michael C, and Masterson, Timothy A. "Intratubular germ cell neoplasms of the testis and bilateral testicular tumors: clinical significance and management options." Indian journal of urology : IJU : journal of the Urological Society of India vol. 26,1 (2010): 64-71. doi: https://doi.org/10.4103/0970-1591.60454
Risk MC, Masterson TA. Intratubular germ cell neoplasms of the testis and bilateral testicular tumors: clinical significance and management options. Indian J Urol. 2010 Jan-Mar;26(1):64-71. doi: 10.4103/0970-1591.60454. PMID: 20535289; PMCID: PMC2878442.
Copy Download .nbib Format: NLM
Share it on

Indian J Urol. 2010 Jan-Mar;26(1):64-71. doi: 10.4103/0970-1591.60454.

Intratubular germ cell neoplasms of the testis and bilateral testicular tumors: clinical significance and management options.

Indian journal of urology : IJU : journal of the Urological Society of India

Michael C Risk, Timothy A Masterson

Affiliations

  1. Department of Urology, Indiana University School of Medicine, Indianapolis, IN, USA.

PMID: 20535289 PMCID: PMC2878442 DOI: 10.4103/0970-1591.60454

Abstract

OBJECTIVES: Intratubular germ cell neoplasia (ITGCN) is the precursor lesion for invasive testicular germ cell tumors (TGCTs) of adolescents and young adults. The rising incidence of these tumors has prompted a rigorous investigation of the etiology, diagnosis and management of ITGCN. Bilateral testicular cancer is closely linked with ITGCN, as patients with unilateral testicular cancer are at the highest risk for a future malignancy in the contralateral testicle.

METHODS: A literature review directed at ITGCN and bilateral testis cancer was performed using the Medline/PubMed database. Our review focused on the pathogenesis, risk factors, diagnosis and treatment regimens utilized.

RESULTS: Major advances have been made in the understanding of ITGCN over the past 30 years. There is evidence that TGCTs arise from ITGCN, ITGCN is closely related to fetal gonocytes, and that events in pre- and perinatal period may result in abnormal persistence of fetal gonocytes leading to ITGCN and subsequent TGCT. Controversy exists regarding the need to biopsy men at increased risk of TGCT, as well as the best approach to managing patients with known ITGCN. Bilateral testicular cancer has excellent outcomes in the current era of platinum-based chemotherapy.

CONCLUSION: The optimal management of patients at risk for ITGCN and future TGCT is still a matter of debate. Individualization of management, including biopsy and treatment, should be based on risk factors for TGCT, compliance with potential surveillance, and patient preferences particularly with regard to fertility.

Keywords: Bilateral testicular cancer; intratubular germ cell neoplasia; testicular germ cell tumor

References

  1. APMIS. 1988 Aug;96(8):667-70 - PubMed
  2. J Urol. 1983 Mar;129(3):522-3 - PubMed
  3. Int J Surg Pathol. 2008 Jan;16(1):21-4 - PubMed
  4. BJU Int. 2002 Sep;90(4):451-5 - PubMed
  5. J Urol. 1987 Mar;137(3):420-3 - PubMed
  6. J Urol. 2003 Jun;169(6):2122-5 - PubMed
  7. Eur Urol. 1995;28(1):25-30 - PubMed
  8. Oncology. 2009;77(1):33-9 - PubMed
  9. J Urol. 2009 Feb;181(2):452-61 - PubMed
  10. J Clin Endocrinol Metab. 1991 Sep;73(3):596-603 - PubMed
  11. Int J Androl. 2008 Apr;31(2):275-87 - PubMed
  12. Semin Urol Oncol. 2002 Nov;20(4):234-8 - PubMed
  13. Mol Hum Reprod. 2004 Jun;10(6):423-31 - PubMed
  14. J Urol. 2001 Dec;166(6):2161-5 - PubMed
  15. Hum Reprod. 2005 Mar;20(3):579-82 - PubMed
  16. Histopathology. 2005 Jul;47(1):48-56 - PubMed
  17. Eur Urol. 1993;23(1):115-8; discussion 119 - PubMed
  18. J Urol. 2004 Jan;171(1):158-60 - PubMed
  19. Scand J Urol Nephrol. 1981;15(3):165-8 - PubMed
  20. J Urol. 2005 May;173(5):1577-9 - PubMed
  21. Eur Urol. 2005 Oct;48(4):662-72 - PubMed
  22. Nat Clin Pract Urol. 2006 Oct;3(10):532-43 - PubMed
  23. Int J Cancer. 2009 Feb 1;124(3):687-9 - PubMed
  24. Int J Androl. 2007 Aug;30(4):398-404; discussion 404-5 - PubMed
  25. J Urol. 1991 Jan;145(1):77-80 - PubMed
  26. Lancet. 1998 Jul 4;352(9121):37 - PubMed
  27. Cancer. 1993 Aug 15;72(4):1308-14 - PubMed
  28. J Clin Oncol. 1996 Dec;14(12):3126-32 - PubMed
  29. Oncogene. 2005 Mar 10;24(11):1882-94 - PubMed
  30. Br Med J (Clin Res Ed). 1986 Nov 29;293(6559):1398-401 - PubMed
  31. Clin Cancer Res. 2004 Dec 15;10(24):8544-7 - PubMed
  32. Int J Androl. 2007 Aug;30(4):406-11; discussion 412 - PubMed
  33. Int J Androl. 1994 Apr;17(2):85-92 - PubMed
  34. Br Med J (Clin Res Ed). 1982 Dec 11;285(6356):1683-6 - PubMed
  35. J Clin Oncol. 2002 Mar 15;20(6):1537-43 - PubMed
  36. Ann Clin Lab Sci. 1983 May-Jun;13(3):185-92 - PubMed
  37. Int J Cancer. 2002 May 10;99(2):229-37 - PubMed
  38. Br J Cancer. 2001 Jul 20;85(2):213-20 - PubMed
  39. Int J Cancer. 2002 May 10;99(2):218-28 - PubMed
  40. Andrologia. 1994 Jul-Aug;26(4):231-4 - PubMed
  41. Lancet. 1979 May 12;1(8124):999-1000 - PubMed
  42. N Engl J Med. 2007 May 3;356(18):1835-41 - PubMed
  43. Ann Oncol. 1998 Jun;9(6):657-60 - PubMed
  44. Int J Androl. 2010 Aug 1;33(4):597-603 - PubMed
  45. Arch Pathol Lab Med. 1985 Jun;109(6):555-9 - PubMed
  46. Cancer. 1990 Jan 1;65(1):1-4 - PubMed
  47. J Urol. 1998 Oct;160(4):1353-7 - PubMed
  48. Histopathology. 1993 Apr;22(4):373-8 - PubMed
  49. J Urol. 1989 Oct;142(4):998-1001: discussion 1001-2 - PubMed
  50. World J Urol. 1996;14 Suppl 1:S55-8 - PubMed
  51. J Pathol. 2005 Jun;206(2):242-9 - PubMed
  52. Mod Pathol. 2008 Nov;21(11):1337-44 - PubMed
  53. J Androl. 2001 Sep-Oct;22(5):818-24 - PubMed
  54. Mod Pathol. 1988 Nov;1(6):475-9 - PubMed
  55. Br J Cancer. 2004 May 4;90(9):1765-70 - PubMed
  56. Cancer. 2005 Nov 15;104(10):2092-8 - PubMed
  57. Lancet. 1985 Jan 12;1(8420):98 - PubMed
  58. Eur Urol. 2003 May;43(5):516-21 - PubMed
  59. J Urol. 2007 Oct;178(4 Pt 1):1440-6; discussion 1446 - PubMed
  60. Hum Pathol. 1997 Apr;28(4):404-10 - PubMed
  61. J Natl Cancer Inst. 2005 Jul 20;97(14):1056-66 - PubMed
  62. J Pathol. 2004 Jul;203(3):849-57 - PubMed
  63. Int J Cancer. 2010 Jan 1;126(1):217-23 - PubMed
  64. J Androl. 2001 Sep-Oct;22(5):781-92 - PubMed
  65. Int J Radiat Oncol Biol Phys. 2001 Jul 15;50(4):909-13 - PubMed
  66. Acta Pathol Microbiol Scand A. 1975 Jan;83(1):127-30 - PubMed
  67. J Urol. 1985 Mar;133(3):413-5 - PubMed
  68. J Androl. 1994 Nov-Dec;15 Suppl:14S-16S - PubMed
  69. Cancer Genet Cytogenet. 1995 Dec;85(2):133-7 - PubMed
  70. BMC Dev Biol. 2008 Nov 07;8:106 - PubMed
  71. BJU Int. 2003 Jul;92(1):43-6 - PubMed
  72. Strahlenther Onkol. 2006 May;182(5):289-92 - PubMed
  73. Cancer. 1990 Mar 1;65(5):1135-42 - PubMed
  74. Br J Urol. 1983 Dec;55(6):780-4 - PubMed
  75. J Urol. 2008 Apr;179(4):1420-3; discussion 1423 - PubMed
  76. Histopathology. 1978 May;2(3):157-70 - PubMed
  77. Jpn J Clin Oncol. 2008 Aug;38(8):578-9 - PubMed
  78. Cancer. 1998 Aug 1;83(3):547-52 - PubMed
  79. Eur Urol. 2008 Jul;54(1):153-8 - PubMed
  80. J Natl Cancer Inst. 1989 Nov 1;81(21):1668-9 - PubMed
  81. Lancet. 1993 Feb 6;341(8841):384-5 - PubMed
  82. Cancer Epidemiol Biomarkers Prev. 2009 Jul;18(7):2042-5 - PubMed
  83. Arch Intern Med. 2009 Feb 23;169(4):351-6 - PubMed
  84. Acta Pathol Microbiol Immunol Scand A. 1984 Sep;92(5):323-9 - PubMed
  85. Br J Urol. 1990 Oct;66(4):420-4 - PubMed
  86. Am J Surg Pathol. 1993 Nov;17(11):1075-91 - PubMed
  87. Acta Oncol. 2000;39(1):105-9 - PubMed
  88. Eur J Cancer. 1993;29A(6):874-6 - PubMed
  89. Acta Endocrinol (Copenh). 1990 Oct;123(4):416-22 - PubMed
  90. Int J Radiat Oncol Biol Phys. 2009 Nov 1;75(3):672-6 - PubMed
  91. World J Urol. 2004 Apr;22(1):2-14 - PubMed
  92. Eur Urol. 2007 Dec;52(6):1710-6 - PubMed
  93. Clin Cancer Res. 2004 Dec 15;10(24):8521-30 - PubMed
  94. Cancer Causes Control. 2008 Dec;19(10):1043-9 - PubMed
  95. Lancet. 1972 Sep 9;2(7776):516-7 - PubMed
  96. Cancer. 1981 Jun 1;47(11):2660-2 - PubMed
  97. Lab Invest. 1995 Feb;72(2):223-31 - PubMed
  98. Cancer Res. 2009 Jun 15;69(12):5241-50 - PubMed
  99. Int J Androl. 2007 Aug;30(4):206-13; discussion 213-4 - PubMed
  100. Eur Urol. 1997;31(2):246-8 - PubMed
  101. Acta Oncol. 2005;44(6):529-36 - PubMed
  102. Int J Cancer. 2000 Feb 1;85(3):370-5 - PubMed
  103. Int J Androl. 2009 Dec;32(6):666-74 - PubMed
  104. Acta Pathol Microbiol Scand A. 1979 Jan;87(1):87-9 - PubMed
  105. Lab Invest. 1994 Dec;71(6):874-8 - PubMed
  106. Urol Int. 2008;80(3):310-6 - PubMed
  107. Am J Surg Pathol. 1987 Jan;11(1):21-9 - PubMed
  108. Semin Diagn Pathol. 1987 Nov;4(4):292-303 - PubMed
  109. J Pediatr. 1985 Mar;106(3):431-6 - PubMed
  110. J Clin Oncol. 1999 Jan;17(1):173-9 - PubMed
  111. APMIS. 2003 Jan;111(1):161-71; discussion 172-3 - PubMed
  112. J Urol. 2003 Oct;170(4 Pt 1):1163-7 - PubMed
  113. Eur Urol. 2007 Jan;51(1):175-83; discussion 183-5 - PubMed

Publication Types